Search Results

How 3 CEOs took their biotechs public Aikium's AI-Driven mRNA Engine Looks to Address Undruggable Disordered Reflect Diverse Chemosensory Adaptations in Lophotrochozoa β-arrestin 1 and integrin-linked kinase interact

He has received substantial, long-term support from international and national competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology companies Professor Christopoulos has over 360 publications, including in leading international journals such as He has served on the Editorial Board of 8 international journals and was a Councillor of the International They also emphasized the significance of fundamental discoveries, the role of biotech, and the need for

He has received substantial, long-term support from international and national competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology companies Professor Christopoulos has over 360 publications, including in leading international journals such as He has served on the Editorial Board of 8 international journals and was a Councillor of the International They also emphasized the significance of fundamental discoveries, the role of biotech, and the need for

and John had a detailed discussion about the prospects of staying in academia versus transitioning to biotech

Kathryn E Livingston is currently a Product Manager at Gator Bio , a biotechnology company providing solutions to researchers studying protein-protein interactions.

Last summer, Julia worked at as the first-ever summer intern at Septerna, the GPCR-based biotechnology

of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery and development biotechnology

Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes Her current research focuses on how metabolic GPCRs cross-talk and interact to regulate appetite and

He earned his master's degree in biotechnology from Jawaharlal Nehru University in India and it was during

oncology research led me to pursue a BSc in Biology & Economics from Carleton University, and an MSc in Biotechnology In my role at Orion Biotechnology, I work at the intersection of science and business, which includes An advocate for trainees at all levels, she served as Service Chairperson and Interim President of the

Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes

following three years on the editorial teams of Nature Structural and Molecular Biology and Nature Biotechnology

Timo De Groof studied Biochemistry and Biotechnology at the University of Ghent where he graduated in During his master's studies, he specialized in Biomedical Biotechnology and Structural Biology/Biochemistry

He is a leader in the study of GPCRs, biased agonism, and also on allosteric interactions between GPCRs two disciplines: Pharmacology & Toxicology and Biology & Biochemistry, a corresponding member of the International Sexton is also a co-founder of the San Francisco-based biotechnology company Septerna Inc . Dr.

Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . Oliver Hartley on the web LinkedIn Orion Biotechnology Dr.

She received her undergraduate degree in Biotechnology from KIIT University in India.

based in South Korea, has recently been named President of GPCR Therapeutics, USA, a newly incorporated Biotechnology

renal/hepatic pathways, and elimination 🔹 Safety First – Identifying toxicity risks and drug-drug interactions networking, mentorship, PhD resilience, COVID-19 challenges, and his aspiration to transition into biotechnology